These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
208 related articles for article (PubMed ID: 16499103)
1. [The impaired immune system and ways of its correction in critically ill patients with acute severe intoxication by neutropic poisons]. Batotsyrenov BV; Livanov GA; Pivovarova LP; Lodiagin AN; Batotsyrenova KhV; Vasil'ev SA Anesteziol Reanimatol; 2005; (6):33-4. PubMed ID: 16499103 [No Abstract] [Full Text] [Related]
2. [Improvement of speech discrimination with cytoflavin in patients with chronic sensorineural deafness]. Zhuravskiĭ SG Vestn Otorinolaringol; 2010; (4):82-6. PubMed ID: 21105353 [No Abstract] [Full Text] [Related]
3. [The use of cytoflavin for the treatment of chronic brucellosis]. Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446 [TBL] [Abstract][Full Text] [Related]
4. [Pharmacologic neuroprotection of the brain in carotid artery surgeries]. Ponomarev EA; Maskin SS; Strepetov NN; Mochaĭlo IuA; Pchelintsev KE Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(6):70-2. PubMed ID: 21905339 [No Abstract] [Full Text] [Related]
5. [The use of cytoflavin in combined neurometabolic therapy of acute cerebral insufficiency associated with acute poisoning with neurotropic poisons]. Aleksandrov MV; Vasil'ev SA; Kuznetsov OA; Andrianov AIu; Shikalova IA; Loladze AT; Batotsyrenov BV Klin Med (Mosk); 2010; 88(2):58-61. PubMed ID: 21105475 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effect of cytoflavin during compression injury of the spinal cord. Bul'on VV; Kuznetsova NN; Selina EN; Kovalenko AL; Alekseeva LE; Sapronov NS Bull Exp Biol Med; 2005 Apr; 139(4):394-6. PubMed ID: 16027862 [TBL] [Abstract][Full Text] [Related]
7. [Pharmacologic correction of hypoxia in patients with acute cerebral failure due to acute poisoning with carbon monoxide and combustion products]. Shilov VV; Vasil'ev SA; Kuznetsov OA; Batotsyrenov BV; Loladze AT Med Tr Prom Ekol; 2012; (6):22-7. PubMed ID: 22997755 [TBL] [Abstract][Full Text] [Related]
8. [Antioxidant therapy in discirculatory encephalopathy]. Antipenko EA; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819 [No Abstract] [Full Text] [Related]
9. [Efficiency of cytoflavin in the treatment of somatoform disorders]. Chutko LS; Surushkina SY; Yakovenko EA; Anisimova TI; Prokopenko SM Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(1):21-24. PubMed ID: 28252599 [TBL] [Abstract][Full Text] [Related]
10. [Efficacy of cytoflavin in the treatment of chronic cerebral ischemia]. Suslina ZA; Klocheva EG; Piradov MA; Rumiantseva SA; Romantsov MG; Kovalenko AL Klin Med (Mosk); 2010; 88(3):50-3. PubMed ID: 20608066 [TBL] [Abstract][Full Text] [Related]
11. [The efficiency of cytoflavin and ozonotherapy in complex treatment of the myasthenia]. Drozd OA; Efremov VV; Dudarev IV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(1):46-9. PubMed ID: 23528494 [No Abstract] [Full Text] [Related]
12. [The use of cytoflavin in the complex treatment of patients with tick-borne encephalitis]. Selezneva AG; Petrova AG Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(7):68-9. PubMed ID: 23011438 [No Abstract] [Full Text] [Related]
13. [Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period]. Bagnenko SF; Mirzabaev AT; Batotsyrenov BV; Gorbachev NB; Miroshnichenko VN; Batotsyrenova KhV; Velikiĭ KF Vestn Khir Im I I Grek; 2011; 170(5):14-6, 18. PubMed ID: 22238957 [TBL] [Abstract][Full Text] [Related]
14. [The influence of cytoflavin on the recovery of cognitive function in elderly people with alcohol abuse]. Ilyinsky NS; Parfenov SA; Haritonova TV; Parfenov YA Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):49-53. PubMed ID: 28300813 [TBL] [Abstract][Full Text] [Related]
15. [The efficacy of cytoflavin used for the correction of psychoemotional and neuroimmune disturbances in the patients presenting with eczema]. Laseev DI; Dikova OV Klin Med (Mosk); 2012; 90(2):50-3. PubMed ID: 22645963 [TBL] [Abstract][Full Text] [Related]
16. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels]. Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354 [TBL] [Abstract][Full Text] [Related]
17. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy]. Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423 [TBL] [Abstract][Full Text] [Related]
18. [Effect of cytoflavin on the recovery of cognitive function after the cardiaс surgery with artificial blood circulation]. Kardash OF; Shestakova LG; Krachak DI; Chernookiĭ OG; Zasetskiĭ AE; Ostrovskiĭ IuP Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(7):76-9. PubMed ID: 21947077 [No Abstract] [Full Text] [Related]
19. [Treatment of alcohol addiction syndrome with cytoflavin]. Belov VG; Parfenov IuA; Okovityĭ SV Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6 Pt 2):54-7. PubMed ID: 23887469 [TBL] [Abstract][Full Text] [Related]